Search research articles
Contact Us
Filters
Showing results (71-80 of 80) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 80 results.
Transplantation Proceedings
|
February 1, 1991
Characterization of a cyclosporine-containing liposome
C E Freise, K Hong, L E Clemens, et al.
Acta Neurologica Scandinavica
|
July 1, 1985
Heredopathia atactica polyneuritiformis: Refsum's disease
F B Gibberd, J D Billimoria, J M Goldman, et al.
Transplantation
|
August 1, 1991
Demonstration of local immunosuppression with methylprednisolone in the sponge matrix allograft model
C E Freise, S Clemmings, L E Clemens, et al.
Biochimica Et Biophysica Acta
|
August 27, 2011
(1)H NMR based metabolomics of CSF and blood serum: a metabolic profile for a transgenic rat model of Huntington disease
Kim A Verwaest, Trung N Vu, Kris Laukens, et al.
Molecular Neurobiology
|
March 18, 2014
Mitochondrial membrane fluidity is consistently increased in different models of Huntington disease: restorative effects of olesoxime
Janett Eckmann, Laura E Clemens, Schamim H Eckert, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 2, 2012
A novel BACHD transgenic rat exhibits characteristic neuropathological features of Huntington disease
Libo Yu-Taeger, Elisabeth Petrasch-Parwez, Alexander P Osmand, et al.
Brain : a Journal of Neurology
|
October 23, 2015
Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat
Laura E Clemens, Jonasz J Weber, Tanja T Wlodkowski, et al.
Cell Metabolism
|
April 9, 2010
CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance
Carmelo Quarta, Luigi Bellocchio, Giacomo Mancini, et al.
Critical Reviews in Oncology/Hematology
|
May 16, 2018
The influence of genetic variation on late toxicities in childhood cancer survivors: A review
E Clemens, A L F van der Kooi, L Broer, et al.
NPJ Precision Oncology
|
July 15, 2021
TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study
A J M Meijer, F A Diepstraten, T Langer, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 80) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 80 results.
Transplantation Proceedings
|
February 1, 1991
Characterization of a cyclosporine-containing liposome
C E Freise, K Hong, L E Clemens, et al.
Acta Neurologica Scandinavica
|
July 1, 1985
Heredopathia atactica polyneuritiformis: Refsum's disease
F B Gibberd, J D Billimoria, J M Goldman, et al.
Transplantation
|
August 1, 1991
Demonstration of local immunosuppression with methylprednisolone in the sponge matrix allograft model
C E Freise, S Clemmings, L E Clemens, et al.
Biochimica Et Biophysica Acta
|
August 27, 2011
(1)H NMR based metabolomics of CSF and blood serum: a metabolic profile for a transgenic rat model of Huntington disease
Kim A Verwaest, Trung N Vu, Kris Laukens, et al.
Molecular Neurobiology
|
March 18, 2014
Mitochondrial membrane fluidity is consistently increased in different models of Huntington disease: restorative effects of olesoxime
Janett Eckmann, Laura E Clemens, Schamim H Eckert, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 2, 2012
A novel BACHD transgenic rat exhibits characteristic neuropathological features of Huntington disease
Libo Yu-Taeger, Elisabeth Petrasch-Parwez, Alexander P Osmand, et al.
Brain : a Journal of Neurology
|
October 23, 2015
Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat
Laura E Clemens, Jonasz J Weber, Tanja T Wlodkowski, et al.
Cell Metabolism
|
April 9, 2010
CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance
Carmelo Quarta, Luigi Bellocchio, Giacomo Mancini, et al.
Critical Reviews in Oncology/Hematology
|
May 16, 2018
The influence of genetic variation on late toxicities in childhood cancer survivors: A review
E Clemens, A L F van der Kooi, L Broer, et al.
NPJ Precision Oncology
|
July 15, 2021
TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study
A J M Meijer, F A Diepstraten, T Langer, et al.
Page
of 8